Ranbaxy Laboratories Ltd - Company Profile

Q: Who are the current directors of Ranbaxy Laboratories Ltd?

The current directors of Ranbaxy Laboratories Ltd are Anthony Hugh Wild, Akihiro Watanabe, Tsutomu Une, Sushil Kumar Patawari, Arun Sawhney, Kazunori Hirokawa, Takashi Shoda, Rajesh Viren Shah, Percy Keku Shroff.

It is a pharma public limited company based in Sas Nagar, Punjab, India, established in 1961.

1961 Sas Nagar, Punjab, India Amalgamated

Last Updated: June 23, 2025

Access Report

About Ranbaxy Laboratories Ltd

Ranbaxy Laboratories Ltd, a amalgamated public limited company, was established on 16 June 1961 in Sas Nagar, Punjab, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: L24231PB1961PLC003747. Registered under ROC Roc Chandigarh. it is listed. It has an authorized capital of ₹300.00 Cr and a paid-up capital of ₹212.83 Cr.

Its leadership includes Anthony Hugh Wild (Director), Akihiro Watanabe (Director), Tsutomu Une (Director). Past directors included Anthony Hugh Wild, Vinay Kumar Kaul, Akihiro Watanabe. It holds no open charges and ₹23.05 Cr settled loans. Its latest AGM occurred on 28 July 2014, with the balance sheet filed on 31 March 2014. It is based at A-41 Industrial Area Phase Viii-A, Sas Nagar, Punjab, 160071.

Company Details

CIN/LLPIN
L24231PB1961PLC003747
Registration Number
003747
Incorporation Date
16 June 1961
Authorized Capital
₹300.00 Cr
Paid-Up Capital
₹212.83 Cr
ROC Code
Roc Chandigarh
Listing Status
Listed
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 300.00 Cr as on 23-06-2025
Paid Up Capital ₹ 212.83 Cr as on 23-06-2025
Company Age 64 Year, 7 Months
Last Filing with ROC 31 Mar 2014
Satisfied Charges ₹ 23.05 Cr as on 23-06-2025

Comprehensive Company Insights

Explore comprehensive insights into Ranbaxy Laboratories Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ranbaxy Laboratories Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Anthony Hugh Wild	Director	09 May 2011	Current
Akihiro Watanabe	Director	09 May 2011	Current
Tsutomu Une	Director	10 May 2010	Current
Arun Sawhney	Managing Director	09 May 2011	Current
Kazunori Hirokawa	Director	09 May 2012	Current
Takashi Shoda	Director	19 Dec 2008	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director Appointed In Casual Vacancy	09 May 2011	Past
Pramod Abcsdd	Director	19 Dec 2008	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	09 May 2011	Past
Pramod Abcsdd	Director	19 Dec 2008	Past
Pramod Abcsdd	Additional Director	07 May 2013	Past
Pramod Abcsdd	Director	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ranbaxy Laboratories.

Enhance accessibility to Ranbaxy Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ranbaxy Laboratories?

Unlock access to Ranbaxy Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹230,500,000.00

Charges Breakdown by Lending Institutions

Bank Of America : 23.05 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Jul 1994	Bank Of America	₹23.05 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ranbaxy Laboratories?

Ranbaxy Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Laboratories's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ranbaxy Laboratories

Recent Activity within the Organization

Annual General Meeting

The activity Ranbaxy Laboratories Ltd last Annual general meeting of members was held on 28 Jul 2014 as per latest MCA records. was completed.
28 Jul 2014
Balance Sheet

Ranbaxy Laboratories Ltd has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Chandigarh. was recorded as a recent event.
31 Mar 2014
Director Appointment

The activity Kazunori Hirokawa was appointed as a Director was appointed as a Director on 09 May 2012 & has been associated with this company since 13 years 9 months . was completed.
09 May 2012
Director Appointment

Progress on Anthony Hugh Wild was appointed as a Director was appointed as a Director on 09 May 2011 & has been associated with this company since 14 years 9 months . was documented.
09 May 2011
Director Appointment

Akihiro Watanabe was appointed as a Director was appointed as a Director on 09 May 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.
09 May 2011
Director Appointment

Progress on Arun Sawhney was appointed as a Managing Director was appointed as a Managing Director on 09 May 2011 & has been associated with this company since 14 years 9 months . was documented.
09 May 2011

Explore recent activity and updates - View Recent Activity